Position in DHR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$725,347
-$34,190 QoQ
Shares Held
3,808
-4.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#1,205
of 2,098 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Aspen Grove Capital, LLC holds $984,048 across 2 Diagnostics & Research names. DHR ranks #1 (73.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
This page
|
3,808 | $725,347 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
516 | $258,701 |
All Filings in DHR
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $725,347 | 3,808 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $759,537 | 4,006 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $909,957 | 3,975 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $786,695 | 3,968 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $917,375 | 4,644 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $898,720 | 4,384 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,016,906 | 4,430 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,227,736 | 4,416 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,166,799 | 4,670 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,170,687 | 4,688 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $941,091 | 4,068 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $223,786 | 902 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,846,320 | 7,693 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,984,310 | 7,873 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,275,976 | 8,575 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||